Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis Pigmentosa

NCT02465749 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

404

Enrollment

OTHER

Sponsor class

Conditions

Retinitis Pigmentosa

Interventions

DRUG: Continuous oxygen
DEVICE: blue light-absorbing sunglasses
DRUG: Compound thrombosis capsule sig: 1.5g/tid
DRUG: Ginkgo biloba pills sig: 300mg/tid;
DRUG: Vitamin B sig: 10mg/tid
DRUG: Vitamin AD sig: 1 tablet/tid

Sponsor

Sun Yat-sen University

Collaborators

[object Object]
[object Object]
[object Object]